Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS Newswire / February 19, 2025 / NanoViricides, Inc. (the ...

Jan. 2, 2025 — A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is ... Study Traces Ebola's Route ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

A suspected Ebola exposure at a Manhattan urgent-care facility had two patients rushed to the hospital by emergency workers in hazmat suits Sunday – but the disease was ruled out. The patients ...

A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Two patients were taken to a New York hospital by hazmat-suited emergency personnel on Sunday due to suspected Ebola exposure at a Manhattan urgent care center, but the infection could be ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

Colorectal cancer (CRC) is a major health problem, with an alarming increase of early-onset CRC (EO-CRC) cases among individuals under 50 years of age. This trend shows the urgent need for ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice.

Cyanobacteria thrive in warm, sunny lakes and ponds that contain excess nitrogen and phosphorus nutrients derived from fertiliser, manure and sewage. When conditions are right, cyanobacteria multiply ...

Shamed Prince Andrew hosted a business meeting at the Royal Lodge with the Chinese ambassador just a few days before a ...